PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Regulatory News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of Major Interest in Shares

28 Aug 2015 07:00

RNS Number : 3695X
ReNeuron Group plc
28 August 2015
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

Reneuron Group

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

No

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

An event changing the breakdown of voting rights

No

Other (please specify):

Placing

Yes

3. Full name of person(s) subject to thenotification obligation:

Invesco Limited

4. Full name of shareholder(s)  (if different from 3.):

5. Date of the transaction and date onwhich the threshold is crossed orreached:

25 August 2015

6. Date on which issuer notified:

27 August 2015

7. Threshold(s) that is/are crossed orreached:

5%

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 

GB00B0DZML60

88,000,000

88,000,000

292,011,939

9.25%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

292,011,939

9.25%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

Invesco Asset Management Limited - 292,011,939

Proxy Voting:

10. Name of the proxy holder:

Invesco Ltd.

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

14. Contact name:

Sam Edwards

15. Contact telephone number:

01491 416 381

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPGUCWRUPAGQM
Date   Source Headline
3rd Jun 20147:00 amRNSNotification of Preliminary Results
14th May 201412:00 pmRNSNotification of Major Interest in Shares
8th May 20149:00 amRNSNotification of Major Interest in Shares
7th May 20147:00 amRNSFurther Data from PISCES Trial
23rd Apr 20147:00 amRNSCorporate update
15th Apr 20147:00 amRNSSigns Lease to New Facility in Wales
27th Mar 20147:00 amRNSUK Clinical Trial Approvals
17th Mar 201411:00 amRNSBlock Listing Six Monthly Review
14th Mar 201412:45 pmRNSSupport for Early Access to Medicines Scheme
21st Jan 20147:00 amRNSPublication of Positive Pre-Clinical Data
27th Dec 20134:40 pmRNSSecond Price Monitoring Extn
27th Dec 20134:35 pmRNSPrice Monitoring Extension
10th Dec 20134:40 pmRNSSecond Price Monitoring Extn
10th Dec 20134:35 pmRNSPrice Monitoring Extension
2nd Dec 20137:00 amRNSInterim Results
19th Nov 20137:00 amRNSNotification of Interim Results
17th Sep 20137:00 amRNSDirectors' Interest in Shares and Share Options
13th Sep 201311:04 amRNSResults of 2013 Annual General Meeting
13th Sep 20137:00 amRNSAGM Trading Update
29th Aug 20137:00 amRNSOrphan Drug Designation
21st Aug 20137:00 amRNSDirector/PDMR Shareholding
21st Aug 20137:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
15th Aug 20137:00 amRNSPosting of Annual Report & Notice of AGM
13th Aug 20137:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
13th Aug 20137:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
12th Aug 20137:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
7th Aug 201311:03 amRNSResult of General Meeting
1st Aug 20137:00 amRNSWins £1.5 Million Grant
22nd Jul 20137:01 amRNS£33 Million Financing Package
22nd Jul 20137:00 amRNSPreliminary Results
18th Jul 20134:40 pmRNSSecond Price Monitoring Extn
18th Jul 20134:35 pmRNSPrice Monitoring Extension
1st Jul 20137:00 amRNSNotification of Preliminary Results
1st Jul 20137:00 amRNSWelcomes House of Lords Report
5th Jun 20134:40 pmRNSSecond Price Monitoring Extn
5th Jun 20134:35 pmRNSPrice Monitoring Extension
28th May 20137:00 amRNSStroke Trial Update
19th Apr 20137:00 amRNSPresentation on Mechanisms of Action
17th Apr 20134:40 pmRNSSecond Price Monitoring Extn
17th Apr 20134:35 pmRNSPrice Monitoring Extension
4th Apr 20134:40 pmRNSSecond Price Monitoring Extn
4th Apr 20134:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.